Lai Hua, Zhan Zheng-Yu, Liu Huai
Medical College of Nanchang University, Nanchang, Jiangxi, P.R. China.
Department of Gynaecology and Obstetrics, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi, P.R. China.
J Int Med Res. 2020 Feb;48(2):300060520904814. doi: 10.1177/0300060520904814.
Thyroid dysfunction may play a role in the development of gestational hypertension. However, this relationship remains unclear. This study was performed to evaluate the association between thyroid hormone parameters during early pregnancy and gestational hypertension.
Women with singleton pregnancies were recruited into this prospective cohort study at 9 to 13 gestational weeks, and their serum thyroid-stimulating hormone, free thyroxine, and free triiodothyronine concentrations were measured using electrochemiluminescence immunoassays. In total, 1226 participants were included in the final analysis.
Of the 1226 participants, 81 subsequently developed gestational hypertension (overall incidence of 6.6%). Compared with women with euthyroidism, both pregnant women with hypothyroidism and those with subclinical hypothyroidism had an increased risk of gestational hypertension (adjusted odds ratio [OR], 3.61; 95% confidence interval [CI], 1.52–8.57 and OR, 2.24; 95% CI, 1.06–4.72, respectively). When the thyroid-stimulating hormone and free thyroxine concentrations were analyzed by quintiles, the women in the highest thyroid-stimulating hormone quintile had a higher risk of gestational hypertension (adjusted OR, 4.22; 95% CI, 1.78–9.05) than the women in the middle quintile.
Our results suggest that hypothyroidism, subclinical hypothyroidism, and a high thyroid-stimulating hormone concentration during early pregnancy are risk factors for gestational hypertension.
甲状腺功能障碍可能在妊娠期高血压的发生中起作用。然而,这种关系仍不明确。本研究旨在评估孕早期甲状腺激素参数与妊娠期高血压之间的关联。
单胎妊娠妇女在妊娠9至13周时被纳入这项前瞻性队列研究,并使用电化学发光免疫分析法测量她们的血清促甲状腺激素、游离甲状腺素和游离三碘甲状腺原氨酸浓度。最终分析共纳入1226名参与者。
在1226名参与者中,81人随后发生了妊娠期高血压(总体发生率为6.6%)。与甲状腺功能正常的女性相比,甲状腺功能减退和亚临床甲状腺功能减退的孕妇发生妊娠期高血压的风险均增加(校正比值比[OR]分别为3.61;95%置信区间[CI]为1.52 - 8.57和OR为2.24;95%CI为1.06 - 4.72)。当按五分位数分析促甲状腺激素和游离甲状腺素浓度时,促甲状腺激素五分位数最高的女性发生妊娠期高血压的风险(校正OR为4.22;95%CI为1.78 - 9.05)高于五分位数处于中间水平的女性。
我们的结果表明,甲状腺功能减退、亚临床甲状腺功能减退以及孕早期促甲状腺激素浓度升高是妊娠期高血压的危险因素。